Company Filing History:

17 out of 4,177

Abbott Laboratories Corporation

The Trustees of Boston College

patents

Years Active: 1992-2014

Loading Chart...

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8748627 - Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome (2014-06-10),

2. 7928243 - Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome (2011-04-19),

3. 7323570 - Farnesyltransferase inhibitors (2008-01-29),

4. 7211595 - Farnesyltransferase inhibitors (2007-05-01),

5. 7056925 - Urea kinase inhibitors (2006-06-06),

6. 6924304 - Cell proliferation inhibitors (2005-08-02),

7. 6831175 - Kinase inhibitors (2004-12-14),

8. 6521658 - Cell proliferation inhibitors (2003-02-18),

9. 6228868 - Oxazoline antiproliferative agents (2001-05-08),

10. 6201001 - Imidazole antiproliferative agents (2001-03-13),

11. 5837868 - Process for preparation of chiral 3-amino-pyrrolidine and analogous (1998-11-17),

12. 5726182 - Quinolizinone type compounds (1998-03-10),

13. 5703244 - Process for preparation of chiral 3-amino-pyrrolidine and analogous (1997-12-30),

14. 5693813 - Process for preparation of 4H-4-oxo-quinolizine-3-carboxylic acid (1997-12-02),

15. 5618813 - Benzo[5.6]pyrano[2.3.4-ij]quinolizine and (1997-04-08),

Title: **Qun Li: Innovator in Metabolic Disease Solutions**

Introduction

Qun Li, based in Libertyville, IL, is an accomplished inventor with a remarkable portfolio of 19 patents. His work primarily focuses on innovations in the treatment and prevention of metabolic diseases, including obesity and diabetes.

Latest Patents

Among his latest contributions to science are his patents related to acetyl-CoA carboxylase (ACC) inhibitors. One of his significant inventions pertains to compounds that inhibit ACC, which can be utilized for preventing or treating metabolic syndrome, type II diabetes, obesity, atherosclerosis, and various cardiovascular diseases in humans. These innovations not only offer a potential pathway for new therapies but also significantly advance the understanding of metabolic conditions.

Career Highlights

Qun Li has established a solid career with notable companies such as Abbott Laboratories Corporation and AbbVie Inc. His role in these organizations has allowed him to lead various research initiatives that have resulted in significant advancements in pharmaceutical sciences.

Collaborations

Throughout his career, Qun Li has collaborated with other distinguished researchers, including Hing L Sham and Daniel T Chu. These partnerships have been instrumental in fostering innovation and facilitating the development of groundbreaking therapeutic solutions.

Conclusion

In summary, Qun Li exemplifies the spirit of innovation in the field of metabolic diseases. His extensive patent portfolio underscores his commitment to improving health outcomes through scientific advancements. As he continues to push the boundaries of research, his contributions will undoubtedly pave the way for new therapeutic approaches in managing complex metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.